carmustine has been researched along with Paraproteinemias in 5 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Paraproteinemias: A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shuttleworth, GN | 1 |
| Cook, SD | 1 |
| Ropner, JE | 1 |
| McLeod, BC | 1 |
| Viernes, AL | 1 |
| Sassetti, RJ | 1 |
| Wöber, C | 1 |
| Schmidbauer, M | 1 |
| Podreka, I | 1 |
| Wenger, S | 1 |
| Pafflmeyer, N | 1 |
| Deecke, L | 1 |
| Meerkin, D | 1 |
| Ashkenazi, Y | 1 |
| Gottschalk-Sabag, S | 1 |
| Hershko, C | 1 |
| Pileri, A | 1 |
| Barbui, T | 1 |
| Boccadoro, M | 1 |
| Comotti, B | 1 |
| Dammacco, F | 1 |
| Gallamini, A | 1 |
| Marmont, F | 1 |
| Neretto, G | 1 |
| Petrucci, MT | 1 |
| Resegotti, L | 1 |
1 review available for carmustine and Paraproteinemias
| Article | Year |
|---|---|
Plasma cell dyscrasia with marrow fibrosis. A reversible syndrome mimicking agnogenic myeloid metaplasia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Diagnosis, Diffe | 1994 |
1 trial available for carmustine and Paraproteinemias
| Article | Year |
|---|---|
Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Cycle; Cyclophosphamid | 1989 |
3 other studies available for carmustine and Paraproteinemias
| Article | Year |
|---|---|
Vanishing corneal epithelial crystals following thalidomide induced resolution of myeloma related paraproteinaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Corneal Diseases; Cyclophosphamide; Doxo | 2002 |
Serum-free light chain analysis by crossed immunoelectrophoresis: correlation with plasmapheresis in light chain disease nephropathy.
Topics: Acute Kidney Injury; Aged; Allopurinol; Calcitonin; Carmustine; Counterimmunoelectrophoresis; Cyclop | 1983 |
Chronic relapsing polyradiculoneuropathy in IgG lambda monoclonal gammopathy of undetermined significance (MGUS)--complete remission following carmustine treatment.
Topics: Adult; Carmustine; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; | 1995 |